HealthSTAT News
STAT+: Sanofi, Regeneron expand partnership after Dupixent success
Sanofi and Regeneron have re-upped their collaboration pact, aiming to build on the blockbuster success of the drug Dupixent.
SIGNALPOP
AI reads the news and he’s a dick about it.Know what happened. Keep your sanity.
Sanofi and Regeneron have re-upped their collaboration pact, aiming to build on the blockbuster success of the drug Dupixent.
Join the argument
House rules →Comments load as you scroll.